Connection

Daniel Wrapp to Antibodies, Neutralizing

Back to Details
This is a "connection" page, showing publications Daniel Wrapp has written about Antibodies, Neutralizing.
Daniel Wrapp
Connection Strength
0.265
Antibodies, Neutralizing
  1. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. 2020 05 28; 181(5):1004-1015.e15.
    View in: PubMed
    Score: 0.124
  2. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci Transl Med. 2021 05 12; 13(593).
    View in: PubMed
    Score: 0.033
  3. Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation. Immunity. 2018 02 20; 48(2):339-349.e5.
    View in: PubMed
    Score: 0.026
  4. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A. 2017 08 29; 114(35):E7348-E7357.
    View in: PubMed
    Score: 0.026
  5. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nat Commun. 2017 02 13; 8:14158.
    View in: PubMed
    Score: 0.025
  6. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol. 2021 02 23; 6(56).
    View in: PubMed
    Score: 0.008
  7. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nat Commun. 2021 01 20; 12(1):469.
    View in: PubMed
    Score: 0.008
  8. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020 10; 586(7830):567-571.
    View in: PubMed
    Score: 0.008
  9. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun. 2020 05 20; 11(1):2601.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.